Client News

Laser Photonics (NASDAQ: LASE) Secures Order From L3Harris Technologies for LaserTower Marking & Engraving System

ORLANDO, Fla., April 09, 2024–(BUSINESS WIRE)–Laser Photonics Corporation (LPC) (NASDAQ: LASE), a leading global developer of industrial laser systems for laser cleaning and other material processing applications, announced that it received an order for its LaserTower COMPACT marking and engraving system from L3Harris Technologies, Inc. “Laser Photonics is proud to supply laser marking equipment to L3Harris, one of the […]

Company Retires $2.6 Million Convertible Note

Company Currently Has No Outstanding Convertible Investments Remaining Bakersfield, CA, April 09, 2024 (GLOBE NEWSWIRE) — Trio Petroleum Corp (NYSE American: “TPET”, “Trio” or the “Company”), a California-based oil and gas company, announced that on April 8, 2024, filed a Form 8-K with the Securities and Exchange Commission (“SEC”) detailing the terms and conditions under […]

OKYO Pharma (NASDAQ: OKYO) to Reschedule Key Opinion Leader Event in Dry Eye Disease to May 2024

LONDON and NEW YORK, April 08, 2024 (GLOBE NEWSWIRE) — OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative ocular therapies for the treatment of inflammatory dry eye disease (DED), a multi-billion-dollar market, and anterior ocular segment diseases including neuropathic corneal pain (NCP), an ocular condition associated with pain but without an FDA […]

Inspire Veterinary Partners (NASDAQ:IVP) Reports Full Year 2023 Financial Results

Full year 2023 revenue increases approximately 70% year-over-year to $16.7 million Outlook for growth in the pet health sector remains attractive with active pipeline of acquisition opportunities Implemented cost reduction initiatives to maximize operational efficiency to deliver profitable growth Major reduction of consultant fees and other discretionary expenses post IPO SG&A savings of at least […]

Longeveron (NASDAQ: LGVN) Announces Pricing of $5.25 Million Public Offering

MIAMI, April 08, 2024 (GLOBE NEWSWIRE) — Longeveron Inc. (NASDAQ: LGVN) (“Longeveron” or “Company”), a clinical stage biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions such as hypoplastic left heart syndrome (HLHS), Alzheimer’s disease and Aging-related Frailty, today announced the pricing of a public offering of 2,234,043 shares of the Company’s Class […]

Longeveron (NASDAQ: LGVN) Issues Letter to Shareholders Highlighting Corporate Strategy, Clinical Pipeline and 2024 Key Priorities and Goals

MIAMI, April 08, 2024 (GLOBE NEWSWIRE) — Longeveron Inc. (NASDAQ: LGVN), a clinical stage biotechnology company developing regenerative medicines, today announced that the Company’s CEO, Wa’el Hashad, issued the following letter to Longeveron shareholders. Dear Shareholders, I am delighted to mark my first anniversary as CEO of Longeveron this month. It has been an extraordinary journey thus […]

1847 Holdings (NYSE American:EFSH) to Acquire a Commercial Cabinet, Door & Millwork Manufacturer with Revenues of $28.6 Million and $5.2 Million of EBITDA in 2023

NEW YORK, NY / ACCESSWIRE / April 8, 2024 / 1847 Holdings LLC (“1847” or the “Company”) (NYSE American:EFSH), a holding company specializing in identifying over-looked, deep value investment opportunities in middle market businesses, today announced the execution of a non-binding Letter of Intent to acquire a large, established millwork, cabinetry and door manufacturer based in […]

Propanc Biopharma’s (OTC Pink: PPCB) CEO Shares Views on Revolutionizing Cancer Treatment: An Inside Look at Drug Development & Strategic Financing

Show with Joel Block, “Your Advantage Play®, In Search of the Ultimate Competitive Advantage” MELBOURNE, Australia, April 08, 2024–(BUSINESS WIRE)–Propanc Biopharma, Inc. (OTC Pink: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company developing novel cancer treatments for patients suffering from recurring and metastatic cancer, today announced that the Company’s CEO, Mr. James Nathanielsz, shares his views […]

CN Energy Group. Inc. (Nasdaq: CNEY) to Present at The Aegis Capital Corp 2024 Virtual Conference

LISHUI, China, April 4, 2024 /PRNewswire/ — CN Energy Group. Inc. (Nasdaq: CNEY) (the “Company” or “CN Energy Group”), a high-tech enterprise specializing in cogeneration of high-quality wood-activated carbon and clean energy, today announced that Steven Berman, Chief Executive Officer of CN Energy Group, will participate in The Aegis Capital Corp 2024 Virtual Conference scheduled for Tuesday, May 7th, 2024, […]

Start Expanding
Your Shareholder Base

Let us help you connect with investors
committed to your success.